VAXCYTE INC (PCVX)

US92243G1085 - Common Stock

78.14  -3.03 (-3.73%)

After market: 78.1 -0.04 (-0.05%)

Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to PCVX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 152.89. This target is 95.66% above the current price.
PCVX was analyzed by 17 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about PCVX.
In the previous month the buy percentage consensus was at a similar level.
PCVX was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 78.14136.35156.06152.89171.15 - 74.49% 99.72% 95.66% 119.03%
Up and Down Grades
Date Firm Action Rating
2024-12-20 Goldman Sachs Initiate Buy
2024-11-06 Cantor Fitzgerald Reiterate Overweight
2024-11-06 Needham Reiterate Buy -> Buy
2024-09-10 Mizuho Maintains Outperform -> Outperform
2024-09-04 B of A Securities Maintains Buy -> Buy
2024-09-03 Leerink Partners Maintains Outperform -> Outperform
2024-09-03 BTIG Maintains Buy -> Buy
2024-09-03 Needham Maintains Buy -> Buy
2024-09-03 Jefferies Maintains Buy -> Buy
2024-08-07 Needham Reiterate Buy -> Buy
2024-06-28 Needham Reiterate Buy -> Buy
2024-06-20 Cantor Fitzgerald Reiterate Overweight
2024-05-09 Cantor Fitzgerald Reiterate Overweight
2024-05-09 Needham Reiterate Buy -> Buy
2024-04-10 Needham Reiterate Buy -> Buy
2024-03-12 Mizuho Maintains Buy -> Buy
2024-02-28 Needham Maintains Buy -> Buy
2024-01-02 B of A Securities Maintains Buy -> Buy
2023-12-07 Mizuho Initiate Buy
2023-11-07 Needham Reiterate Buy -> Buy
2023-08-22 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-08-09 Needham Reiterate Buy -> Buy
2023-05-09 Needham Reiterate Buy
2023-04-18 TD Cowen Initiate Outperform
2023-04-18 B of A Securities Maintains Buy
2023-02-28 Guggenheim Maintains Buy
2023-02-28 Needham Reiterate Buy
2023-01-03 Needham Maintains Buy
2022-12-16 SVB Leerink Initiate Outperform
2022-12-15 Guggenheim Initiate Buy